Axsome Therapeutics (AXSM) Current Debt (2018)
Axsome Therapeutics (AXSM) reported Current Debt of -$833,334 for Q2 2018.
Powered by 
Analysis
Axsome Therapeutics (AXSM) Current Debt (2018) Analysis & Trends
For FY2017, Axsome Therapeutics posted Current Debt of -$277,778.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 3.51 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | -5.75 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | - |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | - |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 208.00 Mn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | - |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | - |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | - |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 64.00 Mn |
| 10 | Axsome Therapeutics | 8.09 Bn | 6.82 Bn | 204.81 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2018 | -833,334.00 |
| Mar 31, 2018 | -833,333.00 |
API Access
Axsome Therapeutics Current Debt API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=current-debt&ticker=AXSM&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "current-debt", "ticker": "AXSM", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=current-debt&ticker=AXSM&period=max&api_key=YOUR_API_KEY");
const data = await res.json();